company background image
EW logo

Edwards Lifesciences NYSE:EW Stock Report

Last Price

US$92.85

Market Cap

US$55.8b

7D

2.2%

1Y

14.5%

Updated

18 Mar, 2024

Data

Company Financials +

Edwards Lifesciences Corporation

NYSE:EW Stock Report

Market Cap: US$55.8b

EW Stock Overview

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally.

EW fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends0/6

Rewards

Risk Analysis

EW passed our risk checks.

Edwards Lifesciences Corporation Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Edwards Lifesciences
Historical stock prices
Current Share PriceUS$92.85
52 Week HighUS$95.27
52 Week LowUS$60.57
Beta1.05
1 Month Change7.84%
3 Month Change23.29%
1 Year Change14.52%
3 Year Change16.56%
5 Year Change47.07%
Change since IPO6,652.73%

Recent News & Updates

Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Feb 21
Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)

Feb 14

Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Feb 08
Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Recent updates

Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Feb 21
Edwards Lifesciences' (NYSE:EW) Soft Earnings Don't Show The Whole Picture

Edwards Lifesciences: EVOQUE FDA Approval; Critical Care Spin-Off (Rating Maintained)

Feb 14

Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Feb 08
Edwards Lifesciences Corporation (NYSE:EW) Released Earnings Last Week And Analysts Lifted Their Price Target To US$90.47

Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly

Jan 28
Here's Why Edwards Lifesciences (NYSE:EW) Can Manage Its Debt Responsibly

The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing

Jan 14
The Returns At Edwards Lifesciences (NYSE:EW) Aren't Growing

Edwards Lifesciences: Undervalued With A Substantial Upside Potential

Jan 09

Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Dec 31
Edwards Lifesciences Corporation's (NYSE:EW) Share Price Not Quite Adding Up

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Dec 17
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences: Sector Derating A Bigger Threat Than Competition Or Slowing Markets

Oct 26

Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Oct 23
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Oct 09
Is Now The Time To Look At Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Sep 26
Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Sep 11
A Look At The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences: Rising Dominance In Structural Heart Disease

Aug 21

Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Jul 16
Does Edwards Lifesciences (NYSE:EW) Have A Healthy Balance Sheet?

Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Jun 30
Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Jun 15
Edwards Lifesciences (NYSE:EW) Is Reinvesting To Multiply In Value

Edwards Lifesciences: Valuation Premium Earned, But Shares Are Not Cheap, Technicals Mixed

Jun 12

Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

May 31
Are Edwards Lifesciences Corporation (NYSE:EW) Investors Paying Above The Intrinsic Value?

Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet

Apr 03
Edwards Lifesciences (NYSE:EW) Has A Rock Solid Balance Sheet

What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Mar 22
What Is Edwards Lifesciences Corporation's (NYSE:EW) Share Price Doing?

Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)

Mar 10
Investors Shouldn't Overlook The Favourable Returns On Capital At Edwards Lifesciences (NYSE:EW)

Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Feb 26
Calculating The Fair Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences downgraded to market perform at Raymond James on growth challenges

Feb 06

Edwards Lifesciences slips as Piper downgrades on challenging setup

Jan 30

Edwards Lifesciences: Short-Term Growth Worries Have Created An Opportunity

Jan 18

Edwards Lifesciences: Catalysts For 2023 And Beyond

Dec 30

Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Dec 28
Is Edwards Lifesciences (NYSE:EW) A Risky Investment?

Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Dec 16
Is It Too Late To Consider Buying Edwards Lifesciences Corporation (NYSE:EW)?

Edwards Lifesciences CEO Michael Mussallem to retire

Dec 08

Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Dec 04
Edwards Lifesciences (NYSE:EW) Knows How To Allocate Capital

Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Nov 22
Estimating The Intrinsic Value Of Edwards Lifesciences Corporation (NYSE:EW)

Edwards Lifesciences down 11% after Q3 misses, revised 2022 EPS guidance

Oct 27

Shareholder Returns

EWUS Medical EquipmentUS Market
7D2.2%-1.4%0.5%
1Y14.5%11.9%29.0%

Return vs Industry: EW exceeded the US Medical Equipment industry which returned 11.9% over the past year.

Return vs Market: EW underperformed the US Market which returned 29% over the past year.

Price Volatility

Is EW's price volatile compared to industry and market?
EW volatility
EW Average Weekly Movement4.7%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.0%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: EW has not had significant price volatility in the past 3 months.

Volatility Over Time: EW's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
195819,800Bernard Zovighianhttps://www.edwards.com

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve.

Edwards Lifesciences Corporation Fundamentals Summary

How do Edwards Lifesciences's earnings and revenue compare to its market cap?
EW fundamental statistics
Market capUS$55.83b
Earnings (TTM)US$1.40b
Revenue (TTM)US$6.00b

39.8x

P/E Ratio

9.3x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EW income statement (TTM)
RevenueUS$6.00b
Cost of RevenueUS$1.38b
Gross ProfitUS$4.63b
Other ExpensesUS$3.22b
EarningsUS$1.40b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)2.33
Gross Margin77.02%
Net Profit Margin23.35%
Debt/Equity Ratio8.9%

How did EW perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.